Ancora Advisors LLC Invests $1.14 Million in LifeVantage Co. (NASDAQ:LFVN)

Ancora Advisors LLC acquired a new position in shares of LifeVantage Co. (NASDAQ:LFVN - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 64,930 shares of the company's stock, valued at approximately $1,138,000. Ancora Advisors LLC owned about 0.52% of LifeVantage as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also added to or reduced their stakes in the stock. Copeland Capital Management LLC bought a new stake in shares of LifeVantage in the 4th quarter worth approximately $65,000. Hillsdale Investment Management Inc. increased its position in LifeVantage by 7.3% in the fourth quarter. Hillsdale Investment Management Inc. now owns 14,720 shares of the company's stock worth $258,000 after buying an additional 1,000 shares during the last quarter. Schonfeld Strategic Advisors LLC bought a new stake in shares of LifeVantage in the fourth quarter valued at $282,000. Barclays PLC lifted its position in shares of LifeVantage by 38.2% during the 3rd quarter. Barclays PLC now owns 41,966 shares of the company's stock valued at $507,000 after buying an additional 11,608 shares during the last quarter. Finally, Jane Street Group LLC bought a new position in shares of LifeVantage during the 4th quarter worth $608,000. Institutional investors own 35.32% of the company's stock.

Wall Street Analyst Weigh In

Separately, Craig Hallum assumed coverage on shares of LifeVantage in a report on Tuesday, January 14th. They set a "buy" rating and a $35.00 price objective on the stock.

Insider Activity at LifeVantage

In other news, Director Raymond B. Greer sold 8,000 shares of the stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $20.15, for a total transaction of $161,200.00. Following the transaction, the director now directly owns 99,288 shares in the company, valued at approximately $2,000,653.20. This represents a 7.46 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 20.65% of the stock is owned by insiders.

LifeVantage Price Performance

NASDAQ LFVN traded up $0.39 during trading on Friday, reaching $12.27. The company's stock had a trading volume of 145,263 shares, compared to its average volume of 139,129. The firm has a fifty day moving average of $14.24 and a 200 day moving average of $16.33. LifeVantage Co. has a one year low of $5.22 and a one year high of $27.38. The stock has a market capitalization of $154.00 million, a PE ratio of 21.91 and a beta of 0.41.

LifeVantage (NASDAQ:LFVN - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.10. LifeVantage had a net margin of 3.46% and a return on equity of 34.29%. The company had revenue of $58.44 million for the quarter, compared to analysts' expectations of $60.99 million.

LifeVantage Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 30th will be given a $0.045 dividend. The ex-dividend date of this dividend is Friday, May 30th. This is a positive change from LifeVantage's previous quarterly dividend of $0.04. This represents a $0.18 annualized dividend and a yield of 1.47%. LifeVantage's payout ratio is 28.57%.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.